Drugs becoming eligible for first Paragraph IV ANDA filing in 2031
Drugs expiring in 2032
Lupin patents expiration
Teva Pharm patents expiration
Carwin Pharm Assoc patents expiration
Procysbi patents expiration
Drugs that contains Aprocitentan
Brynovin patents expiration
